These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34840484)

  • 21. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.
    Xiao Y; Wu D; Shi X; Liu S; Hu X; Zhou C; Tian X; Liu H; Long H; Li Z; Wang J; Tan T; Xu Y; Chen B; Liu T; Zhang H; Zheng S; Hu S; Song J; Tang J; Song J; Cheng Z; Xu W; Shen Y; Yu W; Xu Y; Li J; Zhou J; Wang F; Chen M
    Virulence; 2021 Dec; 12(1):1199-1208. PubMed ID: 33870852
    [No Abstract]   [Full Text] [Related]  

  • 22. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
    Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
    J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.
    Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
    JHEP Rep; 2021 Jun; 3(3):100287. PubMed ID: 34041469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and prognostic model for HBV-related subacute liver failure.
    Xu J; Du F; Yang N; Hou J; Fan Y; Liu X
    Ann Transl Med; 2022 Apr; 10(7):406. PubMed ID: 35530949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience".
    Pati GK; Singh A; Misra B; Misra D; Das HS; Panda C; Singh SP
    J Clin Exp Hepatol; 2016 Mar; 6(1):26-32. PubMed ID: 27194893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study.
    Asghar MS; Ahsan MN; Rasheed U; Hassan M; Jawed R; Abbas MB; Yaseen R; Ali Naqvi SA; Rizvi H; Syed M
    Cureus; 2020 Dec; 12(12):e12294. PubMed ID: 33520498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creatinine-modified Child-Turcotte-Pugh score is a good predictor of a short-term survival in patients with bleeding from esophageal varices.
    Radisavljević M; Bjelaković G; Jović J; Radovanović-Dinić B; Benedoto-Stojanov D; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2017 Jan; 74(1):13-8. PubMed ID: 29350501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding.
    Shalimar ; Vaishnav M; Elhence A; Kumar R; Mohta S; Palle C; Kumar P; Ranjan M; Vajpai T; Prasad S; Yegurla J; Dhooria A; Banyal V; Agarwal S; Bansal R; Bhattacharjee S; Aggarwal R; Soni KD; Rudravaram S; Singh AK; Altaf I; Choudekar A; Mahapatra SJ; Gunjan D; Kedia S; Makharia G; Trikha A; Garg P; Saraya A
    J Clin Exp Hepatol; 2021; 11(3):327-333. PubMed ID: 33519132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approach to the patient with chronic hepatitis B and decompensated cirrhosis.
    Shiffman ML
    Liver Int; 2020 Feb; 40 Suppl 1():22-26. PubMed ID: 32077612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Metabolic Syndrome on the Prognosis of High-Risk Alcoholic Hepatitis Patients: Redefining Alcoholic Hepatitis.
    Habib S; Murakami T; Takyar V; Patel K; Dominguez C; Zhan Y; Mehrpour O; Hsu CH
    Gastroenterology Res; 2023 Feb; 16(1):25-36. PubMed ID: 36895697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum uric acid level in chronic liver disease and its correlation with Child-Pugh score in a tertiary care hospital from South India.
    Noklang S; Noklang I; Chirumamilla SSK; Kannauje PK
    J Family Med Prim Care; 2023 Nov; 12(11):2696-2701. PubMed ID: 38186771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of fifty days in-hospital mortality in patients with culture negative neutrocytic ascites.
    Bal CK; Bhatia V; Daman R
    BMC Gastroenterol; 2017 May; 17(1):64. PubMed ID: 28511674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness of model for end-stage liver disease score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital].
    Song CS; Yoon MY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2011 Jun; 57(6):340-5. PubMed ID: 21694485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis.
    Piotrowski D; Sączewska-Piotrowska A; Jaroszewicz J; Boroń-Kaczmarska A
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32155772
    [No Abstract]   [Full Text] [Related]  

  • 37. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S; Ghani H; Memon S; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):432-5. PubMed ID: 20642940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
    Frager SZ; Szymanski J; Schwartz JM; Massoumi HS; Kinkhabwala M; Wolkoff AW
    Hepatol Commun; 2021 Mar; 5(3):424-433. PubMed ID: 33681677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte Colony-Stimulating Factor Use in Decompensated Cirrhosis: Lack of Survival Benefit.
    Philips CA; Augustine P; Rajesh S; Ahamed R; George T; Padsalgi G; Paramaguru R; Valiathan G; John SK
    J Clin Exp Hepatol; 2020; 10(2):124-134. PubMed ID: 32189927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.